Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine for perioperative pain and recovery in tibial fracture surgery
ChiCTR2200064960Phase 4Not yet recruiting
- Sponsor
- West China Guang'an Hospital of Sichuan University
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine in tibia fracture (2 arms), sponsored by West China Guang'an Hospital of Sichuan University. Primary endpoint: Opioid consumption 72 hours postoperatively. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
tibia fracture
Beyond the preview
Go deeper on ChiCTR2200064960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064960.